A Yale-led analysis of the genomes of more than 1 million people has shed light on the underlying biology of cannabis use disorder and its links to psychiatric disorders, abuse of other substances such as tobacco, and possibly ...
Nov 21, 2023
0
49
Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard ...
Oct 18, 2023
0
44
Prenatal exposure to an anti-nausea drug commonly used in the 1960s and 1970s has been shown to increase risk of colorectal cancer in adult offspring, according to a study by researchers at UTHealth Houston.
Mar 10, 2023
0
57
Researchers from the University of Minnesota have discovered that a protein associated with metabolism, and formerly recognized as a potential therapeutic target for ovarian cancer, may instead be associated with a better ...
Jul 20, 2022
0
9
Researchers have succeeded in establishing a mouse model that develops gastric cancer closely resembling advanced human gastric cancer. Using this model, they have discovered gastric cancer stem cells, i.e. Lgr5+ gastric ...
Dec 22, 2021
0
66
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
Nov 20, 2020
0
3
One of the greatest challenges facing cancer researchers is to understand why some patients don't respond to treatments. In some cases, tumors exhibit what is known as multidrug resistance (MDR), which significantly limits ...
Jul 22, 2022
0
152
Bladder cancer presents a number of challenges when choosing a course of treatment, but researchers at Iowa State University hope their innovative research might help doctors and patients arrive at an optimal treatment plan ...
Dec 7, 2021
0
18
In a study carried out in mice at the University of Chicago, researchers found that lasofoxifene outperformed fulvestrant, the current gold-standard drug, in reducing or preventing primary tumor growth. It also was more effective ...
May 13, 2021
0
419
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published today in Nature Communications.
Oct 22, 2020
0
92
